The Business
Research Company’s Antibody Contract Manufacturing Global Market Report 2023 is
the most detailed report available on the market, including broad forecast
periods and multiple geographies. The report covers the historic period – 2010-2021,
and the forecast period – 2023-2032. The Antibody Contract Manufacturing Global
Market Report 2023 evaluates antibody contract manufacturing market size,
growth rate, drivers, trends, and major companies.
The report provides
a global perspective by covering 60 geographies and focusing on major economies
in each region – Asia-Pacific, Western Europe, Eastern Europe, North America,
South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs
And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12665&type=smp
The global
antibody contract manufacturing market is expected to grow from $11.18 billion
in 2022 to $12.84 billion in 2023 at a compound annual growth rate (CAGR) of
14.82%. The Russia-Ukraine war disrupted the chances of global economic
recovery from the COVID-19 pandemic. The war between these two countries has
led to economic sanctions on multiple countries, surge in commodity prices, and
supply chain disruptions, causing inflation across goods and services and
resulted in increased interest rates affecting many markets across the globe.
The antibody contract manufacturing market is expected to reach $21.79 billion
in 2027 at a CAGR of 14.13%.
The rising number
of clinical trials is expected to propel the growth of the antibody contract
manufacturing market going forward. Clinical trials are research studies
conducted with human participants to evaluate the safety and effectiveness of
new medical treatments, interventions, or diagnostic procedures. The number of
clinical trials involving antibody-based therapeutics or diagnostics expands,
for high-quality antibodies, ensuring a timely and compliant supply for
clinical trials. For instance, in May 2023, according to ClinicalTrials.gov, a
part of the National Institutes of Health (NIH), a US-based government agency
responsible for conducting and supporting medical research, in all 50 states of
the United States and 221 countries, the number of registered clinical trials
studies climbed from 399,499 in 2022 to 437,533 in 2023. Additionally, around
241,498 studies, or 53% of the total, were registered outside the United
States, compared to 140,492 studies (31%) registered just in the United States.
Therefore, the rising number of clinical trials is driving the growth of the
antibody contract manufacturing market.
Get More Information On The Antibody Contract
Manufacturing Market Report:
The antibody
contract manufacturing market segments in the report are:
1) By Product:
Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source:
Mammalian, Microbial
3) Scale Of
Operation: Preclinical, Clinical, Commercial
4) By End-User:
Biopharmaceutical Companies, Research Laboratories, Other End Users
The table of contents in TBRC’s antibody contract manufacturing market
report includes:
1. Executive Summary
2. Antibody Contract Manufacturing Market Characteristics
3. Antibody Contract Manufacturing Market Trends And Strategies
4. Antibody Contract Manufacturing Market - Macro Economic Scenario
5. Global Antibody Contract Manufacturing Market Drivers and Restraints
.
32. Global Antibody Contract Manufacturing Market Competitive
Benchmarking
33. Global Antibody Contract Manufacturing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Antibody Contract Manufacturing
Market
35. Antibody Contract Manufacturing Market Future Outlook and Potential
Analysis
36. Appendix
Learn About Us:
The Business Research Company is a market intelligence
firm that pioneers in market, company, and consumer research. TBRC’s specialist
consultants are located globally and are experts in a wide range of industries
that include healthcare, manufacturing, financial services, chemicals, and
technology. The firm has offices located in the UK, the US, and India, along with
a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market
Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment